Funding Opportunities / RFPs
Currently Available Funding Opportunities / Requests for Proposals (RFPs):
ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): budgets of up to US$60,000 for clinical repurposing trials in any disease led by underserved researchers in any LMIC (as defined by the World Bank). CLOSED; SUBMISSIONS UNDER REVIEW.
US Based Clinical Repurposing Trials to Address Diversity, Equity and Inclusion (DEI): budgets of up to $75,000 for clinical repurposing trials from any US based research institution to address Diversity, Equity and Inclusion (DEI), including repurposing clinical trials that EITHER are led by an underrepresented researcher (as defined by the NIH) OR address health disparities among underserved patients (as defined by the NIH) OR both. CLOSED; SUBMISSIONS UNDER REVIEW.
Repurposing Research to Address Diversity, Equity and Inclusion in the Greater Chicago Area: budgets of up to $100,000 for clinical repurposing trials from any research institution in the greater Chicago area to address Diversity, Equity and Inclusion (DEI), including repurposing clinical trials that EITHER are led by an underrepresented researcher (as defined by the NIH) OR address health disparities among underserved patients (as defined by the NIH) OR both. CLOSED; SUBMISSIONS UNDER REVIEW.
Clinical Repurposing Research to Impact Veterans/Military: INVITE ONLY, up to $75,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans or active military, including mental health, PTSD and brain injuries. CLOSED; FUNDING DECISIONS MADE.
Repurposing Research to Improve Patient Outcomes in Meniere’s Disease and Related Diagnoses: Clinical and Preclinical Projects: clinical repurposing trials (budgets up to $100,000) and preclinical repurposing research (budgets up to $50,000) in Meniere’s disease as well as other vertigo and hearing loss-related diagnoses, including benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis. CLOSED; FUNDING DECISIONS MADE.
APPLY FOR FUNDING:
If you’re already a ProposalCentral user, log into our new site from the top right corner.
If you don’t have a ProposalCentral login, create a login here.
Closed Funding Opportunities / Requests for Proposals (RFPs):
2022
- Drug Repurposing Clinical Trials to Impact Blood Cancers: for clinical repurposing trials testing repurposed drugs in any blood cancer from anywhere in the world – accepting budgets of up to $75,000.
- Repurposing Research to Address Diversity, Equity and Inclusion (DEI) in the Greater Chicago Area: for clinical repurposing trials from Chicagoland research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $100,000.
- US Based Clinical Repurposing Trials to Address Diversity, Equity and Inclusion (DEI): for clinical repurposing trials in any disease from US research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $70,000.
- CureAccelerator Live! for Diversity, Equity and Inclusion (DEI) in Rare Diseases: for clinical repurposing trials in any rare disease from US research institutions testing any repurposed therapy and that support the US-based Cures Within Reach DEI efforts for underrepresented racial / ethnic minority patients and researchers – accepting budgets of up to $70,000.
- ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): for clinical repurposing trials in any disease led by an underserved researcher in any LMIC, as defined by the World Bank – accepting budgets of up to $50,000.
2021
- Clinical Repurposing Research to Impact Veterans: repurposing clinical trials in any disease area impacting veterans, including mental health, PTSD and brain injuries – up to $50,000
- CureAccelerator Live! for Pediatric Rare Diseases: repurposing clinical trials in any pediatric rare disease – up to $50,000
- Repurposing Research to Improve Clinical Patient Outcomes in Meniere’s Disease and Related Symptoms / Consequences: repurposing clinical trials to address Meniere’s disease and symptoms / consequences of Meniere’s disease, including tinnitus and hearing loss – up to $100,000
- Preclinical Repurposing Research to Address Meniere’s Disease and Related Symptoms / Consequences: repurposing preclinical project to address Meniere’s disease and symptoms / consequences of Meniere’s disease, including tinnitus and hearing loss – up to $50,000
- Repurposing Research Led by a US-Based Racial / Ethnic Minority Principal Investigator: clinical repurposing trials in any disease led by a US-based racial / ethnic minority PI underrepresented in biomedical research, as defined by the NIH – up to $70,000
- Repurposing Research to Address Racial / Ethnic Health Disparities in the Greater Chicago Area: clinical repurposing trials from any research institution in the greater Chicago area to address racial / ethnic health disparities in communities of color as defined by the NIH – up to $80,000
- ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): clinical repurposing trials led by an underserved researcher in any LMIC, as defined by the World Bank – up to $50,000
2020
- ReGRoW Pilot: clinical repurposing research projects from PIs based in low and lower-middle income countries (LMICs) to find treatments for patients in LMICs
- Rare Blood Cancers and Retinitis Pigmentosa: clinical repurposing research projects – up to $50,000
- Meniere’s Disease: clinical repurposing research projects – up to $100,000
- Meniere’s Disease: pre-clinical repurposing research projects – up to $50,000
- Canine-Focused Comparative Trials: repurposing research projects from PIs based in North America and Europe – up to $25,000
- Chicagoland Clinical Repurposing Trials: repurposing research projects from PIs based in the Chicago area – up to $50,000